The effect of disease-associated mutations on the folding pathway of human prion protein

被引:126
作者
Apetri, AC
Surewicz, K
Surewicz, WK
机构
[1] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA
关键词
D O I
10.1074/jbc.M313581200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Propagation of transmissible spongiform encephalopathies is believed to involve the conversion of cellular prion protein, PrPC, into a misfolded oligomeric form, PrPSc. An important step toward understanding the mechanism of this conversion is to elucidate the folding pathway(s) of the prion protein. We reported recently (Apetri, A. C., and Surewicz, W. K. (2002) J. Biol. Chem. 277, 44589 - 44592) that the folding of wild-type prion protein can best be described by a three-state sequential model involving a partially folded intermediate. Here we have performed kinetic stopped-flow studies for a number of recombinant prion protein variants carrying mutations associated with familial forms of prion disease. Analysis of kinetic data clearly demonstrates the presence of partially structured intermediates on the refolding pathway of each PrP variant studied. In each case, the partially folded state is at least one order of magnitude more populated than the fully unfolded state. The present study also reveals that, for the majority of PrP variants tested, mutations linked to familial prion diseases result in a pronounced increase in the thermodynamic stability, and thus the population, of the folding intermediate. These data strongly suggest that partially structured intermediates of PrP may play a crucial role in prion protein conversion, serving as direct precursors of the pathogenic PrPSc isoform.
引用
收藏
页码:18008 / 18014
页数:7
相关论文
共 58 条
[1]   Kinetic intermediate in the folding of human prion protein [J].
Apetri, AC ;
Surewicz, WK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (47) :44589-44592
[2]   Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis [J].
Booth, DR ;
Sunde, M ;
Bellotti, V ;
Robinson, CV ;
Hutchinson, WL ;
Fraser, PE ;
Hawkins, PN ;
Dobson, CM ;
Radford, SE ;
Blake, CCF ;
Pepys, MB .
NATURE, 1997, 385 (6619) :787-793
[3]   Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme [J].
Canet, D ;
Last, AM ;
Tito, P ;
Sunde, M ;
Spencer, A ;
Archer, DB ;
Redfield, C ;
Robinson, CV ;
Dobson, CM .
NATURE STRUCTURAL BIOLOGY, 2002, 9 (04) :308-315
[4]   Transmissible spongiform encephalopathies, amyloidoses and yeast prions: Common threads? [J].
Caughey, B .
NATURE MEDICINE, 2000, 6 (07) :751-754
[5]   Transmissible spongiform encephalopathies and prion protein interconversions [J].
Caughey, B ;
Chesebro, B .
ADVANCES IN VIRUS RESEARCH, VOL 56: NEUROVIROLOGY: VIRUSES AND THE BRAIN, 2001, 56 :277-311
[6]   SECONDARY STRUCTURE-ANALYSIS OF THE SCRAPIE-ASSOCIATED PROTEIN PRP 27-30 IN WATER BY INFRARED-SPECTROSCOPY [J].
CAUGHEY, BW ;
DONG, A ;
BHAT, KS ;
ERNST, D ;
HAYES, SF ;
CAUGHEY, WS .
BIOCHEMISTRY, 1991, 30 (31) :7672-7680
[7]   STRUCTURAL CLUES TO PRION REPLICATION [J].
COHEN, FE ;
PAN, KM ;
HUANG, Z ;
BALDWIN, M ;
FLETTERICK, RJ ;
PRUSINER, SB .
SCIENCE, 1994, 264 (5158) :530-531
[8]   Prion diseases of humans and animals: Their causes and molecular basis [J].
Collinge, J .
ANNUAL REVIEW OF NEUROSCIENCE, 2001, 24 :519-550
[9]  
Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO
[10]  
2-H